Liming Hu Selected Research

Liming Hu Research Topics

Disease

9	Neoplasms (Cancer) 09/2021 - 12/2011
3	Inflammation (Inflammations) 04/2024 - 03/2018
3	Intracranial Aneurysm (Cerebral Aneurysm) 01/2021 - 05/2020
2	Wounds and Injuries (Trauma) 04/2024 - 03/2011
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 07/2023 - 01/2020
2	Lung Neoplasms (Lung Cancer) 01/2021 - 09/2016
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021 - 01/2015
1	Cough 04/2024
1	Asthma (Bronchial Asthma) 04/2024
1	COVID-19 01/2024
1	Mitochondrial Diseases (Mitochondrial Disease) 10/2023
1	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 09/2022
1	Rupture 09/2022
1	Gastroesophageal Reflux (GERD) 01/2022
1	Adenocarcinoma of Lung 01/2021
1	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2021
1	Breast Neoplasms (Breast Cancer) 10/2018
1	Bacterial Infections (Bacterial Infection) 10/2018
1	Infections 03/2018
1	Melanoma (Melanoma, Malignant) 01/2018
1	Malignant Mesothelioma 09/2016
1	Mesothelioma 09/2016
1	Hepatocellular Carcinoma (Hepatoma) 06/2016
1	Fatigue 02/2015
1	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 01/2015

Drug/Important Bio-Agent (IBA)

3	Biomarkers (Surrogate Marker)IBA 04/2024 - 02/2015
3	ergosterol-5,8-peroxideIBA 01/2017 - 06/2016
2	CollagenIBA 04/2024 - 09/2022
2	Acetic Acid (Vinegar)FDA LinkGeneric 07/2023 - 01/2020
2	Protein-Lysine 6-Oxidase (Lysyl Oxidase)IBA 09/2022 - 01/2021
2	CytokinesIBA 01/2021 - 05/2020
2	Peptides (Polypeptides)IBA 09/2020 - 03/2018
2	AminesIBA 01/2019 - 12/2011
2	AsbestosIBA 09/2016 - 01/2015
1	Eosine Yellowish-(YS) (Eosin)IBA 04/2024
1	Hematoxylin (Haematoxylon)IBA 04/2024
1	InterleukinsIBA 04/2024
1	Periodic AcidIBA 04/2024
1	Interleukin-6 (Interleukin 6)IBA 04/2024
1	Interleukin-17 (Interleukin 17)IBA 04/2024
1	Nucleic AcidsIBA 01/2024
1	CalciumIBA 10/2023
1	Omeprazole (Prilosec)FDA LinkGeneric 01/2022
1	RNA (Ribonucleic Acid)IBA 09/2021
1	Transfer RNA (tRNA)IBA 09/2021
1	ErbB Receptors (EGF Receptor)IBA 01/2021
1	Tyrosine Kinase InhibitorsIBA 01/2021
1	AZD0156IBA 01/2021
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021
1	Immune Checkpoint InhibitorsIBA 09/2020
1	sodium bisulfide (NaHS)IBA 01/2020
1	QuinazolinesIBA 01/2019
1	isoliquiritigenin (GU 17)IBA 01/2019
1	Phosphotransferases (Kinase)IBA 01/2019
1	Casein Kinase II (Casein Kinase 2)IBA 01/2019
1	Benzoic Acid (Potassium Benzoate)FDA Link 01/2019
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 01/2019
1	silmitasertibIBA 01/2019
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 10/2018
1	Contrast MediaIBA 10/2018
1	1-phenyl-3,3-dimethyltriazene (PDT)IBA 03/2018
1	ChlorophyllIBA 03/2018
1	Anti-Bacterial Agents (Antibiotics)IBA 03/2018
1	Monophenol Monooxygenase (Tyrosinase)IBA 01/2018
1	Fluorescent Dyes (Fluorescent Probes)IBA 01/2018
1	Urea (Carbamide)FDA LinkGeneric 01/2018
1	ORALIT (ORS)IBA 09/2016
1	TeaIBA 09/2016
1	Apoptosis Regulatory ProteinsIBA 06/2016
1	SterolsIBA 06/2016
1	rhodiolosideIBA 02/2015
1	MelatoninIBA 02/2015
1	AICA ribonucleotide (ZMP)IBA 02/2015
1	pregnenolone sulfateIBA 02/2015
1	sebacic acidIBA 02/2015
1	Sorbitol (Yal)FDA Link 02/2015
1	Taurine FDA Link 02/2015
1	N-acetylserotoninIBA 02/2015
1	2-methoxyestroneIBA 02/2015
1	Cortisone FDA Link 02/2015
1	geranyl diphosphateIBA 02/2015
1	Crocidolite Asbestos (Blue Asbestos)IBA 01/2015
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2015
1	Gefitinib (Iressa)FDA Link 01/2015
1	Drinking WaterIBA 01/2015
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2015
1	EstersIBA 12/2011
1	Drug CarriersIBA 12/2011
1	1,2- dipalmitoyl- 3- phosphatidylethanolamineIBA 12/2011

Therapy/Procedure

2	Therapeutics 01/2019 - 12/2011
2	Photochemotherapy (Photodynamic Therapy) 03/2018 - 01/2018
1	Chinese Traditional Medicine (Traditional Chinese Medicine) 04/2024
1	Immunotherapy 09/2020
1	Sutures (Suture) 03/2011
1	Lasers (Laser) 03/2011